ADCT-301
ADCT-301-103
Phase 1 small_molecule terminated
Quick answer
ADCT-301 for Head and Neck Cancer Squamous Cell Carcinoma is a Phase 1 program (small_molecule) at ADC Therapeutics SA with 1 ClinicalTrials.gov record(s).
Program details
- Company
- ADC Therapeutics SA
- Indication
- Head and Neck Cancer Squamous Cell Carcinoma
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- terminated